Hong-Lin Yin
- Topics
- Myasthenia Gravis and Thymoma (4 papers)Urinary and Genital Oncology Studies (3 papers)Prostate Cancer Treatment and Research (3 papers)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Hong-Lin Yin
26 papers receiving 224 citations
Peers
Comparison fields: 5 of 54
- Molecular Biology 115
- Cancer Research 64
- Oncology 50
- Pathology and Forensic Medicine 30
- Surgery 28
Countries citing papers authored by Hong-Lin Yin
This map shows the geographic impact of Hong-Lin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Lin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Lin Yin more than expected).
Fields of papers citing papers by Hong-Lin Yin
This network shows the impact of papers produced by Hong-Lin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Lin Yin. The network helps show where Hong-Lin Yin may publish in the future.
Co-authorship network of co-authors of Hong-Lin Yin
This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Lin Yin. A scholar is included among the top collaborators of Hong-Lin Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Lin Yin. Hong-Lin Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 70 | |
| 3 | 9 | |
| 4 | 10 | |
| 5 | 21 | |
| 6 | 13 | |
| 7 | 18 | |
| 8 | [Expression of ID3 protein in prostate cancer and its clinicopathological significance]. | 1 |
| 9 | 20 | |
| 10 | [Clinicopathologic features of granulocytic sarcoma: a study of 38 cases]. | 2 |
| 11 | [Clinicopathological characterization of prostatic small cell carcinoma: a case report and review of the literature]. | 1 |
| 12 | [Primary Burkitt lymphoma of the seminal vesicle: a case report and review of the literature]. | 3 |
| 13 | [Analysis of 12 206 cases of external pathology consultation]. | 1 |
| 14 | [Primary peripheral T-cell lymphoma of the penis: a case report and review of the literature]. | 3 |
| 15 | [Expression of VEGF in prostate cancer and its correlation with ET-1]. | 2 |
| 16 | [Histologic subtyping and prognosis of thymoma: a study of 108 cases]. | 2 |
| 17 | [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance]. | 5 |
| 18 | 6 | |
| 19 | [Gleason histologic grading of prostate carcinoma in relation to serum PSA, PSA in situ and immunohistochemical expression of 34 beta E12 and P504S]. | 1 |
| 20 | Mycobacterial spindle cell pseudotumor of lymph nodes after receiving Bacille Calmette-Guerin (BCG) vaccination. | 4 |
About Hong-Lin Yin
Hong-Lin Yin is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Immunology and Allergy, having authored 27 papers that have together received 228 indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (4 papers), Urinary and Genital Oncology Studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (64 citations), Oncology (50 citations) and Molecular Biology (115 citations). Hong-Lin Yin has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Yuxin Wang, Zhifeng He, Qian Zhang, Qi Xiao, Chengwan Xia, Jianquan Wang, Qingang Hu, Yumei Pu, Qiu Rao and Xiaojun Zhou. Their work appears in journals such as PLoS ONE, RSC Advances and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.